Related Experiment Video
Updated: Aug 23, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
[Update in arrhythmogenic right ventricular cardiomyopathy: genetic, clinical presentation and risk stratification]
María T Tomé Esteban1, José M García-Pinilla, William J McKenna
1Cardiology in the Young, Department of Cardiology, The Heart Hospital, London, UK.
Insights
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart condition often missed in early stages. Research focuses on genetic mutations and fibrofatty tissue replacement for better diagnosis and understanding of sudden cardiac death risk.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a challenging genetic heart muscle disease.
- It is a leading cause of sudden cardiac death in young individuals.
- The disease involves fibrofatty tissue substitution in the myocardium, often leading to missed early diagnoses.
Purpose of the Study:
- To review current concepts in ARVC, focusing on genetic studies.
- To summarize diagnostic challenges and advancements.
- To discuss prognosis and new diagnostic techniques.
Main Methods:
- Review of genetic studies on ARVC.
- Analysis of diagnostic criteria and techniques.
- Examination of international registries and phenotypic variations.
Main Results:
- Mutations in cell adhesion genes (e.g., plakoglobin, desmoplakin) are implicated in ARVC pathogenesis.
- Animal models support the theory of adhesion junction disruption leading to fibrofatty replacement and arrhythmias.
- Phenotypic variations and complexity necessitate international collaborative efforts.
Conclusions:
- Understanding the genetic basis of ARVC is crucial for improved diagnosis and pathogenesis insights.
- Early detection remains a challenge due to subtle initial symptoms.
- Ongoing research and international registries are vital for managing ARVC and reducing sudden cardiac death risk.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy (ARVC), or dysplasia, is a genetic heart muscle disease whose diagnosis is often a challenge for the clinician. It is one of the commonest causes of sudden cardiac death in the young. The classic description of the disease describes the end stage of a process where the myocardium, mainly of the right ventricle, has been substituted by fibrofatty tissue. Thus the early stages of the disease with subtle symptomatology are often missed. Unfortunately the risk of a fatal outcome is no less severe. The genetic basis is under investigations. Disease causing mutations in important cell adhesion genes (plakoglobin, desmoplakin) provide the basis for improved diagnosis and understanding of the pathogenesis. Animal models support the pathogenic theory that alterations on the integrity of the adhesion junction is followed by a cellular death and progressive fibrofatty replacement, the substrate for ventricular arrhythmias. Due the growing complexity and numerous phenotypic variations reported, sometimes in the same family, international registries have been created. The present review aims to summarise the current concepts on ARVC emphasising the genetic studies, the diagnosis, new diagnostic techniques and prognosis.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
